Get started
Author

Ruben V. Huis in ‘t Veld

Observed names: R. In 't Veld, Ruben V Huis In't Veld, Ruben V. Huis In't Veld, Ruben V. Huis in 't Veld, Ruben V. Huis in't Veld, Ruben Victor Huis in 't Veld, Ruben Victor Huis in ‘t Veld
OpenAlex ID: A5000936490
Current Challenges and Opportunities of Photodynamic Therapy against Cancer
2023 · Ruben V. Huis in ‘t Veld, Jeroen Heuts, et al. · Pharmaceutics · 159
PDF
Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy
2022 · Yang Hao, Chih Kit Chung, et al. · Pharmaceutics · 60
PDF
Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
2022 · Yang Hao, Chih Kit Chung, et al. · Molecular Biomedicine · 43
PDF
Photodynamic cancer therapy enhances accumulation of nanoparticles in tumor-associated myeloid cells
2019 · Ruben V. Huis in 't Veld, Laila Ritsma, et al. · Journal of Controlled Release · 37
PDF
M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer
2022 · Ruben V. Huis in ‘t Veld, Pablo Lara, et al. · Journal of Nanobiotechnology · 33
PDF
Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon Cancer
2021 · Pablo Lara, Ruben V. Huis in ‘t Veld, et al. · Pharmaceutics · 28
PDF
Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
2021 · Ruben Victor Huis in ‘t Veld, Candido G. Da Silva, et al. · Pharmaceutics · 23
PDF
Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors
2023 · Ruben V. Huis in ‘t Veld, Sen Ma, et al. · Cancer Immunology Immunotherapy · 20
PDF
In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity
2023 · Sen Ma, Ruben V. Huis In't Veld, et al. · Investigative Ophthalmology & Visual Science · 15
PDF
Targeting ocular malignancies using a novel light-activated virus-like drug conjugate
2024 · Sen Ma, Ruben V. Huis In't Veld, et al. · Advances in Ophthalmology Practice and Research · 7
Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma Model
2024 · Sen Ma, Ruben V. Huis in't Veld, et al. · Investigative Ophthalmology & Visual Science · 7
The Potential of Nano-Vehicle Mediated Therapy in Vasculitis and Multiple Sclerosis
2017 · R. In 't Veld, C.G. Da Silva, et al. · Current Pharmaceutical Design · 6
Treatment of Conjunctival Melanoma Cell Lines With a Light-Activated Virus-Like Drug Conjugate Induces Immunogenic Cell Death
2024 · Sen Ma, Ruben V. Huis In't Veld, et al. · Investigative Ophthalmology & Visual Science · 5
PDF
A novel virus-like drug conjugate (VDC) in combination with immune checkpoint inhibitors for the treatment of primary tumors and distant metastasis.
2022 · Ruben Victor Huis in 't Veld, Sen Ma, et al. · Journal of Clinical Oncology · 3
The role of pigmentation in tumor treatment with the investigational virus-like drug conjugate belzupacap sarotalocan in an in vitro and in vivo murine model
2024 · Sen Ma, Ruben V Huis In't Veld, et al. · Photodiagnosis and Photodynamic Therapy
Works count: 15
Citation count: 446
H-index: 9
I10-index: 9
Year
Topic
Type